↓ Skip to main content

Validation of the flemish CARES, a quality of life and needs assessment tool for cancer care

Overview of attention for article published in BMC Cancer, August 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Validation of the flemish CARES, a quality of life and needs assessment tool for cancer care
Published in
BMC Cancer, August 2016
DOI 10.1186/s12885-016-2728-9
Pubmed ID
Authors

Bojoura Schouten, Johan Hellings, Elke Van Hoof, Patrick Vankrunkelsven, Paul Bulens, Frank Buntinx, Jeroen Mebis, Dominique Vandijck, Ward Schrooten

Abstract

The Cancer Rehabilitation Evaluation System (CARES) is a quality of life (QOL) and needs assessment instrument of US origin that was developed in the 90's. Since November 2012 the copyright and user fee were abolished and the instrument became publicly available the present study aims to reinvestigate the psychometric properties of the CARES for the Flemish population in Belgium. The CARES was translated into Flemish following a translation-back translation process. A sample of 192 cancer patients completed the CARES, concurrent measures, and questions on socio-demographic and medical data. Participants were asked to complete the CARES a second time 1 week later, followed by some questions on their experiences with the instrument. Internal consistency, test-retest reliability, content validity, construct validity, concurrent validity and feasibility of the CARES were subsequently assessed. The Flemish CARES version demonstrated excellent reliability with high internal consistency (range .87-.96) and test-retest ratings (range .70-.91) for all summary scales. Factor analysis replicated the original factor solution of five higher order factors with factor loadings of .325-.851. Correlations with other instruments ranging from |.43|-|.75| confirmed concurrent validity. Feasibility was indicated by the low number of missing items (mean 2.3; SD 5.0) and positive feedback of participants on the instrument. The Flemish CARES has strong psychometric properties and can as such be a valid tool to assess cancer patients' QOL and needs in research, for example in international comparisons. The positive feedback of participants on the CARES support the usefulness of this tool for systematic assessment of cancer patients' well-being and care needs in clinical practice. ClinicalTrials.gov: NCT02282696 (July 16, 2014).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 35%
Student > Ph. D. Student 3 15%
Student > Bachelor 2 10%
Professor 2 10%
Student > Doctoral Student 2 10%
Other 1 5%
Unknown 3 15%
Readers by discipline Count As %
Nursing and Health Professions 5 25%
Psychology 4 20%
Medicine and Dentistry 3 15%
Sports and Recreations 1 5%
Social Sciences 1 5%
Other 1 5%
Unknown 5 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2016.
All research outputs
#3,947,687
of 8,331,095 outputs
Outputs from BMC Cancer
#1,160
of 3,500 outputs
Outputs of similar age
#117,690
of 251,917 outputs
Outputs of similar age from BMC Cancer
#59
of 197 outputs
Altmetric has tracked 8,331,095 research outputs across all sources so far. This one has received more attention than most of these and is in the 50th percentile.
So far Altmetric has tracked 3,500 research outputs from this source. They receive a mean Attention Score of 3.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.